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Abstract: In bone tissue engineering, the design of 3D systems capable of recreating composition,
architecture and micromechanical environment of the native extracellular matrix (ECM) is still a
challenge. While perfusion bioreactors have been proposed as potential tool to apply biomechanical
stimuli, its use has been limited to a low number of biomaterials. In this work, we propose the
culture of human mesenchymal stem cells (hMSC) in biomimetic mineralized recombinant collagen
scaffolds with a perfusion bioreactor to simultaneously provide biochemical and biophysical cues
guiding stem cell fate. The scaffolds were fabricated by mineralization of recombinant collagen in
the presence of magnesium (RCP.MgAp). The organic matrix was homogeneously mineralized with
apatite nanocrystals, similar in composition to those found in bone. X-Ray microtomography images
revealed isotropic porous structure with optimum porosity for cell ingrowth. In fact, an optimal
cell repopulation through the entire scaffolds was obtained after 1 day of dynamic seeding in the
bioreactor. Remarkably, RCP.MgAp scaffolds exhibited higher cell viability and a clear trend of
up-regulation of osteogenic genes than control (non-mineralized) scaffolds. Results demonstrate the
potential of the combination of biomimetic mineralization of recombinant collagen in presence of
magnesium and dynamic culture of hMSC as a promising strategy to closely mimic bone ECM.
Keywords: scaffold; perfusion bioreactor; collagen; apatite nanoparticles; magnesium; human
mesenchymal stem cell; osteogenesis
1. Introduction
Severe trauma, congenital malformations or disease can compromise the integrity
and functionality of the skeletal system to the extent of requiring bone implants [1].
Over 2 million bone surgeries are conducted each year in the Unites States and around
10 million of Chinese patients suffered from limited limb functions [2]. Bone is the second
most transplanted tissue after blood and an ever-increasing worldwide demand of bone
graft substitutes can be expected in the coming years [1]. The forefront of tissue engineering
involves the isolation of stem cells from bone marrow or adipose tissue aspirated from the
patient, their expansion and differentiation on synthetic porous scaffolds and the further
implantation of the composite with the aim of fostering osteoinduction and osteoconduc-
tion for rapid repair of the defect site [3,4]. The design of ideal bone biomaterial plays
a vital role in bone repair. Biomaterial design aims to recapitulate the organization and
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composition of natural bone extracellular matrix (ECM) where stem cells grow in vivo. To
guide stem cell interaction and fate, multiple stimulus including physical (porosity, sur-
face nanotopography, stiffness, shear stress and electrical forces) and biochemical (surface
chemistry, growth factors o proteins) have been proposed [2,5–7].
In vivo bone mineralization has inspired the design of advanced biomaterials, so-
called biomimetic, mimicking the hierarchical organization and composition of native
tissue at nanoscale level [8–11]. Bone is a nanocomposite made up of self-assembled colla-
gen fibers (accounting for 35 wt.%) strengthened by inter and intrafibrillar mineralization
of apatite (Ap) nanocrystals (65 wt.%) [12]. Ap nanoparticles consist on non-stoichiometric
hydroxyapatite [HA, Ca10(PO4)6(OH)2] containing foreign ions in its structure, e.g., CO32−,
Mg2+, Sr2+ [13]. Bone grafts have been designed through a biologically inspired mineraliza-
tion protocol by which magnesium-substituted hydroxyapatite nanoparticles crystallized
into naturally derived type I collagen fibers mimicking the process occurring during bio-
logical neo-ossification [9,14–17]. In vitro studies demonstrated the potential of this hybrid
scaffolds to induce, orchestrate, and harmonize the osteogenic differentiation of human
bone marrow stem cells (hMSCs) and in vivo studies revealed its osteoinductive nature [17].
However, the difficulties in processing and purification with batch-to-batch variability and
the risk of disease transmission of natural collagen have stimulated keen interest in devis-
ing biomaterial based on recombinant collagen [18,19]. Recombinant collagen is engineered
with precise chemical composition and molecular weight, enabling the introduction of
specific amino acid sequences and the large-scale production for industrial exploitation [18].
Recently, we have investigated the biomimetic mineralization of recombinant collagen
peptide (RCP) based on human collagen type I enriched in arginine-glycine-aspartic acid
sequences, which are specific sites favoring the attachment of a large number of adhesive
ECM, blood and cell surface proteins [20]. We carried out RCP mineralization in the pres-
ence of magnesium to closer mimic bone Ap composition (0.5–1%) [21] and we observed
that Mg stabilized the precursor amorphous calcium phosphate and inhibited apatite
crystal growth along c-axis, resulting in more isometric Ap nanocrystals than mineraliza-
tion protocol without magnesium [20]. Atomic force microscopy observations revealed
that mineralization in the presence of Mg provided homogeneous mineral distribution in
the organic matrix and surface roughness similar to that found in bone [20]. Further in vitro
studies demonstrated that RCP mineralization in the presence of magnesium potentially
promoted cell migration through the inner areas of the scaffold and higher gene and protein
expressions of osteogenic markers comparing with the results of mouse mesenchymal stem
cells grown on mineralized scaffolds without magnesium [22]. In spite of these good
results, even after 14 days of cell culture, few cells arrived to the bottom inner part of the
scaffolds [22]. This is likely due to the fact that in vitro static cell culture on tridimensional
scaffolds presents scarce mass transport prompting to limited cell colonization through few
hundred microns and apoptosis or necrosis of cells at the central core of the scaffold [23].
Over the last decade, bioreactor systems have been engineered to improve the trans-
port of gases and nutrients and enhance cell distribution, overcoming the main limitations
of static cell culture [7,23–25]. Perfusion bioreactors also generate dynamic biophysical
stimuli such as shear stress and mechanical loading [7,23–25]. Cells in bone tissues (i.e., os-
teoclast, osteoblast, osteocytes and MSCs) are mechanosensitive and respond to biophysical
factors in the environment [23]. It has been widely demonstrated that dynamic cell culture
in different type of scaffolds such as ceramic scaffolds, metallic scaffolds, decellularized
bone matrix from animal sources, synthetic polymer scaffolds, e.g., poly (l-latic acid), or
hybrid scaffolds made of HA and chitosan, enhanced cell proliferation and osteogenic
differentiation [26,27]. Several in vivo studies also demonstrated that MSC preconditioning
in bioreactor prior to implantation enhanced in vivo results as quantity and quality of new
bone [23,28,29]. A more recent work demonstrated that bioreactor-based preconditioning
augments the bone-forming potential of human bone marrow aspirates [30].
Despite the numerous works on dynamic culture of MSC in perfusion bioreactor,
there is still a lack of simulation of the real environment due to the low biomimicry of
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used scaffold. In this work, we propose the combination of perfusion bioreactor and
recombinant collagen scaffolds mineralized in the presence of magnesium (RCP.MgAp) to
simultaneously provide biochemical and biophysical cues and closely simulate the growth
environment of stem cells in vivo. The structure and chemical composition of biomimetic
scaffold (RCP.MgAp) was deeply characterized. Then, hMSC seeding on the resulting 3D
biomaterial was assessed under static and dynamic conditions in a perfusion bioreactor.
We also evaluated the osteogenic potential of biomimetic mineralized recombinant collagen
scaffolds versus control recombinant collagen scaffolds by gene expression.
2. Results
2.1. Scaffold Characterization
The microstructure of RCP.MgAp scaffold was evaluated via micro-computed to-
mography (µCT). Tridimensional porous scaffolds with interconnected and randomly
distributed pores (i.e., isotropic structure) were obtained via freeze-drying of mineralized
solutions (Figure 1). Analysis of surface pore size of 200 µCT scans revealed a wide pore
size distribution ranging from 50 to 600 µm and giving rise to 90 ± 0.4% of porosity. Non-
mineralized recombinant collagen scaffolds used as a control on in vitro assay showed
similar pore size distribution (Figure S1) and porosity (88 ± 0.6%).
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Figure 1. Structural characterization of recombinant collagen in the presence of magnesium (RCP.MgAp) scaffold (diam-
eter = 4 mm; height = 4 mm) by micro-computed tomography. (a) Transversal and (b) longitudinal section of the scaffold. 
Scale bar=1 mm. (c) Graph bar displays pore size distribution estimated with ImageJ software. 
Scanning electron microscope (SEM) image of RCP.MgAp scaffold shows pores di-
ameter between 100–300 μm (Figure 2). The energy dispersive X-ray spectroscopy (EDS) 
mapping of the cross-section (Figure 2) reveals a uniform distribution of calcium, phos-
phorus and magnesium belonging to the mineral phase along with the nitrogen of the 
organic matrix. From these results we can infer that a homogeneous hybrid material was 
obtained through the biomimetic mineralization of RCP. In fact, the Ap nanoparticles are 
completely embedded in the organic matrix as indicated by the SEM images at high mag-
nification of the wall of the pore (Figure 3a). The nanoparticles have a length of approxi-
mately 150–250 nm and a width of around 30–50 nm (Figure 3a), as previously observed 
by transmission electron images of MgAp nanoparticles synthesized through the same 
biomimetic mineralization approach [20]. 
Figure 1. Structural characterization of recombinant collagen in the presence of magnesium (RCP.MgAp) scaffold (diame-
ter = 4 mm; height = 4 mm) by micro-computed tomography. (a) Transversal and (b) longitudinal section of the scaffold.
Scale bar=1 mm. (c) Graph bar displays pore size distribution estimated with ImageJ software.
Scanning electron microscope (SEM) image of RCP.MgAp scaffold shows pores di-
ameter between 100–300 µm (Figure 2). The energy dispersive X-ray spectroscopy (EDS)
mapping of the cross-section (Fig r ) reveals a uniform distribution of calcium, ph s-
horus and magnesium belong ng to the mineral phase along with the nitr gen of the
organic matrix. From these results we can infer that a homogeneous hybrid material was
obtained through the biomimetic mineralization of RCP. In fact, the Ap nanoparticles
are completely embedded in the organic matrix as indicated by the SEM images at high
magnification of the wall of the pore (Figure 3a). The nanoparticles have a length of approx-
imately 150–250 nm and a width of around 30–50 nm (Figure 3a), as previously observed
by transmission electron imag s of MgAp nanoparticles syn hesized through the same
biomimetic mineralization approach [20].




Figure 2. Energy dispersive X-ray spectroscopy (EDS) elemental maps of an area of RCP.MgAp scaffold showing the 
presence of P (yellow), Ca (blue) and Mg (green) of the mineral phase closely related to the N signal of the collagen (red). 
SEM image of the scaffold on the left displays the area of the mapping. Scale bar = 100 μm. 
 
Figure 3. (a) SEM images of cross-section of RCP.MgAp scaffold. High magnification image of the wall of the pores shows 
the incorporation of Ap into the organic matrix. (b) Fourier-transform infrared spectroscopy (FTIR) spectrum of 
RCP.MgAp scaffold. (c) TGA curve of the top, middle and base of the scaffold. Inset displays X-ray diffraction (XRD) 
pattern of the sample exhibiting characteristic reflections of hydroxyapatite (HA, ASTM card file No 09-432). 
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The chemical composition and structure of RCP.MgAp scaffolds were also analyzed
by Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and
X-ray diffraction (XRD). FTIR spectrum (Figure 3b) shows the amide bands of recombinant
collagen at 1245 cm−1 (amide III), 1540 cm−1 (amide II), 1650 cm−1 (amide I), 3074 cm−1
(amide B) and 3421 cm−1 (amide A) [31,32]. The wagging (γ), bending (δ) and asymmetrical
stretching (ν) modes of CH2 of collagen are also visible [31]. It also displays characteristic
bands of Ap: the triply degenerated asymmetric stretching mode of phosphate group
(ν3PO4) at 1032 cm−1 with shoulders at 1046 cm−1 and 1087 cm−1 and triply degenerated
bending mode of phosphate (ν4PO4) at 561 cm−1 and 602 cm−1 [33]. FTIR spectrum shows
bending (ν2CO3) and stretching (ν3CO3) vibration mode of carbonate that corresponds
with B-type carbonated apatite (partial substitution of PO43− groups mainly by CO32−
ions) [33]. The formation of nanocrystalline apatite was confirmed by XRD. Figure 3c
(inset) exhibits broad reflections ascribed to hydroxyapatite (HA, ASTM card file No 09-
432). The broadness of the peaks indicates low crystallinity and nanosized dimensions of
the diffracting crystal domains. The ratio of mineral content of RCP.MgAp scaffold was
quantitatively assessed by TGA of the top, middle and base of the scaffold to evaluate
the mineral distribution (Figure 3c). TGA curves mainly exhibit three decomposition
steps: the first loss from 25 ◦C to 170 ◦C due to the decomposition of adsorbed and
bound water (accounting for 6–7 wt.%); the second loss from 170 ◦C to 420 ◦C due to
degradation of recombinant collagen; and the third loss from 420 ◦C to 650 ◦C attributed to
the combustion of organic residues. The resultant residue after 650 ◦C corresponds directly
to the inorganic phase amount, which was 26 wt.% at the top and around 29 wt.% at the
middle and base of the scaffold. This finding confirms a homogeneous distribution of Ap
along the scaffold. Chemical composition of hybrid scaffolds was quantitatively evaluated
by inductively coupled plasma optical emission spectroscopy (ICP-OES) indicating the
following composition: Ca (9.4 ± 0.8 wt.%), PO4 (12.0 ± 1.4 wt.%) and Mg (0.8 ± 0.1 wt.%).
2.2. In Vitro Studies
2.2.1. Optimization of hMSC Seeding on Scaffolds
Cell seeding was initially optimized in order to achieve a homogeneous distribution
of cells over the scaffold volume. First, 2 × 106 cells were seeded on top of the scaffolds
and maintained in static culture for 24 h (Figure 4a). This strategy led to the formation of
cell clusters at the top and the edges of both mineralized (RCP.MgAp) and non-mineralized
(RCP) scaffolds (Figure 4b). To overcome this undesired cell distribution, perfusion biore-
actor was used for dynamic cell seeding using the same cell density (Section 4.4.3). The
homogeneity of cell distribution within the scaffold improved significantly after 24 h of
dynamic cell culture. Nonetheless, the MTT staining showed low cell density (pale vio-
let) likely due to the large volume of the scaffolds (Figure 4b)), giving rise to low MTT
absorbance value (Supplementary Figure S2). The increase of cell suspension density to
5 × 106 cells per scaffold allowed to obtain a homogeneous cell distribution with higher cell
density through the whole volume, as shown MTT staining images of the lateral surface
and the cross-section of the scaffolds (Figure 4b) and MTT absorbance graph (Supple-
mentary Figure S2). These conditions were then used to further evaluate the capability
of RCP.MgAp scaffold in inducing osteogenic differentiation of hMSC using a perfusion
bioreactor.
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2.2.2. Dynamic Osteogenic Differentiation in a Perfusion Bioreactor 
The impact of the mineral phase on osteogenic differentiation of hMSC was studied 
after 15 days of dynamic cell culture in the perfusion bioreactor. At the end of the experi-
ment, scaffolds were stained with MTT to assess cell viability and distribution over the 
scaffolds (Figure 5) and cells were collected for gene expression analysis (Figure 6). Inter-
estingly, the presence of mineral provides a significant increase on cell viability for hMSC 
on RCP.MgAp scaffolds in comparison to the non-mineralized RCP scaffolds (Figure 5a). 
However, it was observed a homogeneously distributed staining for both materials (Fig-
ure 5b). As expected, the not-seeded scaffolds (control) showed no staining. Therefore, the 
increase of MTT absorbance is assumed to be associated with an increase of hMSC prolif-
eration on mineralized scaffolds, rather than a hitch from the RCP scaffolds. 
 
Figure 5. Cell viability of hMSC after 15 days of dynamic osteogenic culture. (a) MTT absorbance from full scaffolds was 
measured and normalized with dimethyl sulfoxide blank values. Statistical analysis using student t-test, * p < 0.05, n (RCP) 
= 3, n (RCP.MgAp) = 5. (b) Representative cross-sections images from MTT staining of non-seeded scaffolds (on top) and 
hMSC seeded scaffolds (on bottom) after 15 days of dynamic culture with osteogenic differentiation factors. 
Regarding the gene expression analysis, hMSC cultivated on RCP.MgAp scaffolds 
showed the trend of superior osteogenic gene expression than hMSC cultivated on scaf-
folds without mineral (RCP) (Figure 6). Remarkably, the expression of Col1a1 on 
RCP.MgAP scaffolds showed a considerable increase in comparison to the control. De-
spite this clear trend, statistical analysis indicated no significance (p > 0.05). These results 
are indicative of an augmented differentiation into osteogenic lineage of hMSC cultivated 
in the mineralized scaffolds. 
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[34]. In bone tissue engineering, 3D scaffolds must be designed to provide a more conduc-
tive structure for hMSC attachment, growth and osteogenic differentiation [34]. Herein, 
bioinspired scaffolds mimicking the osteogenic niche of cancellous bone have been de-
signed through biomimetic mineralization of recombinant collagen and freeze-drying. 
This technique is one of the most common methodologies used to fabricate tridimensional 
porous scaffolds with tailored pore size, porosity and pore distribution (aligned or iso-
tropic structures) [10,35]. These are critical parameters that directly affect the fluid shear 
stress sensed by the cells when cell medium is perfused through the scaffold in the biore-
actor [36]. This mechanical stimulus has been pointed out as a potent promoter of hMSC 
osteodifferentiation [27,37]. A recent review suggests that the cultivation of hMSC under 
oscillatory or pulsative flow in 3D scaffolds (100–800 μm) and in the presence of osteoin-
ductive supplements provides optimal effect on hMSC osteogenesis [23]. In this line, we 
obtained 3D scaffolds with pore size distribution (50–700 μm) inside the range previously 
commented. Moreover, the most frequent value of pore diameter (100–300 μm) has been 
designated as the optimum cell migration and new bone formation [38–40]. The porosity, 
closed to that found in cancellous bone, also provides a suitable structure for cell coloni-
zation and fluid exchanges [38–40]. Conversely, porosity has a detrimental effect on the 
scaffold mechanical properties, as reviewed by Deville et al. [35]. Future work, also in-
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3. Discussion
The synergy of 3D scaffolds and perfusion bioreactors represents a promising strategy
to more accurately simulate growth environment of stem cells in the human body [34]. In
bone tissue engineering, 3D scaffolds must be designed to provide a more conductive struc-
ture for hMSC attachment, growth and osteogenic differentiation [34]. Herein, bioinspired
scaffolds mimicking the osteogenic niche of cancellous bone have been designed through
biomimetic mineralization of recombinant collagen and freeze-drying. This technique is one
of the most common methodologies used to fabricate tridimensional porous scaffolds with
tailored pore size, porosity and pore distribution (aligned or isotropic structures) [10,35].
These are critical parameters that directly affect the fluid shear stress sensed by the cells
when cell medium is perfused through the scaffold in the bioreactor [36]. This mechanical
stimulus has been pointed out as a potent promoter of hMSC osteodifferentiation [27,37].
A recent review suggests that the cultivation of hMSC under oscillatory or pulsative flow
in 3D scaff lds (100–800 µm) and in the presence of osteoinductive supplements provides
optimal effect on hMSC osteogenesis [23]. In this line, we obtained 3D scaffolds with pore
size distribution (50–700 µm) insid the range previously comment d. Moreover, the most
frequ value of pore diameter (100–300 µm) has been designated as the optimum c ll
migration and n w bone formation [38–40]. The porosity, closed t that found in cancellous
b ne, also provides a suitable structure for cell colonization and fluid exchang s [38–40].
Conversely, porosity has a detrimental effect on the scaffold m chanical properties, as
reviewed by Devil e et al. [35]. Future ork, also involving in vivo s dies, will require
a thorough study to achieve a compromise between the requirements of porosity for c ll
ing owth and fluid exchange and the need of suitable me ical properti s.
Biomimetic mineralization of RCP in the presence of magnesium promoted the nucle-
ation of Ap nanoparticles int the organic matrix providing a homogeneous int gratio of
the mineral h se along the entire scaffolds, as indicated by EDS ap and TGA an lysis.
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SEM image of the wall of the pores confirmed the formation of acicular nanoparticles
in the organic matrix. These results fit with previous atomic force microscopy observa-
tions revealing a homogeneous distribution of Ap nanoparticles into the RCP matrix at
nanoscale level when mineralization was carried out in the presence of Mg [20]. Conversely,
RCP mineralization in the absence of Mg prompted to Ap nanoparticle aggregation, hetero-
geneous mineral distribution at nanoscopic scale and therefore, higher surface roughness
value [20]. Regarding the chemical composition, these nanoparticles contain magnesium
(close to the values found in bone, 0.5–1%) [21] and carbonate ions substituting phosphate
group in apatite crystal structure, named as B-type carbonate substitution. This type of
carbonate substitution is the preferred in bone apatite [41]. Whereas carbonate ions are
by far the most abundant exogenous ion of bone apatite [41], magnesium is one of the
more important minor cations in bone tissue [42]. Both ions, magnesium and carbonate,
are typically found in younger bone triggering to poor crystalline apatite [14,43]. In fact,
XRD pattern of RCP.MgAp scaffolds confirmed the precipitation of poor crystalline apatite
as biological ones [12].
In addition to biomaterial features, cell distribution, mass transport and biomechanical
stimulation are also highly relevant factors on bone regeneration [44]. In this scenario, per-
fusion bioreactors have been demonstrated to provide a homogeneous distribution of cells
inside 3D scaffolds, an adequate transport of nutrients and oxygen and mechanical stimuli
by way of fluid shear stress [26,44,45]. In this work, hMSC have been cultured on mineral-
ized recombinant collagen scaffolds in the presence of Mg in a perfusion bioreactor in order
to simultaneously provide them with the adequate physic-chemical and mechanical stimuli
for osteogenic differentiation. The first step was to optimize hMSC seeding on 3D hybrid
scaffolds. Whereas some authors carried out cell seeding in static conditions and then
moved cell/scaffold construction inside the bioreactor for dynamic culture [46–49], others
studies implemented dynamic conditions for cell seeding and culture [30,50,51]. Static cell
seeding is by far the most commonly used seeding method but it provides low seeding
efficiencies and non-uniform cell distribution [52]. Herein, the static cell seeding promoted
the formation of capsule cell layer at the surface of the scaffold (closer to 2D system) due to
the physical limitation of fluid penetration extensively reported in the literature, especially
for bone substitutes constructs where a large scaffold volume is often required [53–55].
The dynamic seeding provided a more uniform cell distribution in both scaffolds, miner-
alized (RCP.MgAp) and non-mineralized ones (RCP, control), revealing their feasibility
to support cell attachment. After 15 days of dynamic cell culture, mineralized scaffolds
showed a significant increase on cell growth and scaffold repopulation comparing with
non-mineralized scaffolds. This effect may be associated to the scaffold surface chemistry
and topography [6]. Respect to the former, apatite nanoparticles are widely considered as
ideal biomaterial for bone regeneration due to its excellent biocompatibility, biodegrad-
ability and osteoconductive and osteoinductive potential [5]. Moreover, the presence of
magnesium may favor cell proliferation on mineralized scaffolds since magnesium is in-
volved in bone homeostasis by enhancing attachment and differentiation of osteoblastic
cells and accelerating the mineralization process [56]. Another factor to consider is the
unique surface properties of nanocomposite materials that are capable of mediating specific
protein adsorption and promoting cell adhesion, proliferation and differentiation [6]. In
fact, a clear trend for upregulation of genes related to osteogenic commitment of primary
hMSC cultured in mineralized scaffolds (RCP.MgAp) when compared with non-modified
scaffolds (RCP) was observed. Despite this trend, no statistically significant differences
in the expression of the tested genes were observed due to variations between donors, a
fact widely reported and accepted in the literature for primary cells derived from different
patients [57]. Moreover, the presence of osteogenic factors (L-ascorbic acid, dexamethasone
and β-glycerophosphate) also induced dramatic differences in levels of bone-specific gene
induction in hMSC exposed to osteo-inductive media, as previously reported by Donald
G. Phinney et al. [58]. Yet, a prominent upregulation of Col1a1, an early precursor protein
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responsible for the formation of very strong mature type I collagen fibers, was observed for
RCP.MgAp scaffolds.
In a nutshell, the biomimetic mineralization of RCP in the presence of magnesium
might provide chemical signaling favoring hMSC viability and osteogenesis while perfu-
sion bioreactor enhances cell distribution inside the scaffolds, closely recreating 3D bone
ECM environment. Further studies are required in order to verify the osteogenic potential
of mineralized recombinant collagen scaffolds. In addition, this work paves the way on
the development of in vitro models that better recapitulate the in vivo cell niche, which are
essential for the progress of fundamental biology and clinical translation (review in [59]).
4. Materials and Methods
4.1. Materials
Recombinant collagen peptide (RCP), commercially available as Cellnest™ (Fujifilm,
Tilburg, The Netherlands), is produced by a fermentation process using genetically modi-
fied yeast as described previously [60]. RCP sequence is based on human collagen type I
and comprises 571 amino acids. Unless noted, all reagents were purchased from Sigma-
Aldrich (Taufkirchen, Germany).
4.2. Fabrication of Hybrid Scaffolds
Mineralization of RCP was carried out by a neutralization reaction in order to obtain a
hybrid scaffold with a 30 wt.% of mineral content (i.e., magnesium-doped hydroxyapatite).
Briefly, 0.75g of RCP was dissolved in 5 mL of phosphoric acid aqueous solution (270 mM)
through magnetically stirring at 40 ◦C. Once that RCP was completely dissolved, it was
added dropwise into 5 mL of a calcium hydroxide aqueous suspension (450 mM) containing
magnesium ions in a molar ratio Mg/Ca of 0.15. After 2 h of mineral maturation at room
temperature, the mineralized solution was poured into a 48-well plate, frozen at −20 ◦C
overnight and freeze-dried (0.1 mbar; 5Pascal; Cinquepascal srl, Trezzano sul Naviglio,
Italy). RCP aqueous solution (7.5 wt.%) was also freeze-dried in 48-well plate to fabricate
control scaffolds for in vitro experiments. We obtained cylindrical scaffolds with a diameter
of 10 mm and a height of 10 mm. The scaffolds were crosslinked by dehydrothermal
treatment (DHT) at 160 ◦C under vacuum for 48 h. Finally, the scaffolds were sterilized by
autoclaving.
4.3. Characterization of the Material
4.3.1. Structural Characterization
The porosity of the scaffold and its three-dimensional structure was determined by
X-ray computerized axial microtomograph (Zeiss Xradia 510 Versa, Oberkochen, Germany)
of the Centre for Scientific Instrumentation (University of Granada, CIC-UGR). For each
scaffold (d = 4 mm, h = 4 mm), 2000 radiographic images (image resolution: 5 µm, X-ray
energy: 80 keV, exposure time = 3 s) were obtained. ImageJ software (version 1.48v; NIH,
Bethesda, MD, USA) was used to analyze pore size distribution and porosity in 200 images.
The 3D image reconstruction of the scaffold was performed with Dragonfly Pro (Object
Research System, Montreal, QC, Canada).
Scaffold structure and composition was analyzed with a Field Emission Scanning
Electron Microscope (FESEM, Zeiss SUPRA40V from CIC-UGR) equipped with an Oxford
energy-dispersive X-ray spectrophotometer (EDS) and operating at 3–15 KeV. Scaffolds
were cut with a razor blade, mounted on aluminum stubs using a carbon tape and sputtered
with a thin carbon film. Mineral distribution and composition were analyzed with Aztec
3.0 SP1 EDS software.
4.3.2. Characterization of Chemical Composition
Fourier-transform infrared (FTIR) spectrum of RCP.MgAp scaffolds was recorded on
a Nicolect 380 FTIR spectrometer (Thermo Fisher Scientific, Waltham, MA, United States
of Ameria). Scaffold was cut with a razor blade in a small piece of 5 mg that was mixed
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with 250 mg of potassium bromide (KBr). Then, the mixture was pressed at 10 tons into
7 mm diameter disk. A pure KBr disk was used as blank. The spectrum was registered
from 4000 cm−1 to 400 cm−1 with a resolution of 2 cm−1 by accumulating 100 scans.
Thermogravimetry analysis was performed using a simultaneous thermal analyzer
(STA 449 Jupiter Netzsch Geratebau, Selb, Germany) with a heating rate of 10 ◦C/min up
to 1000 ◦C in nitrogen flow.
X-Ray diffraction (XRD) pattern of RCP.MgAp scaffolds was recorded in a D8 Advance
diffractometer (Bruker, Germany) using a Cu Kα radiation (λ = 1.5418 Å) generated at
40 kV and 40 mA. The pattern was recorded from 10◦ to 60◦ (2θ) with a step size of 0.002◦
and a scan rate of 5 s step−1.
The chemical composition (Ca, P and Mg) was analyzed by inductively coupled
plasma optical emission spectrometry (ICP-OES; Agilent Technologies 5100 ICP-OES,
Santa Clara, CA, USA). A 20 mg portion of scaffold was dissolved in 2 mL of ultrapure
nitric acid and then diluted up to 100 mL with Milli-Q water. Three replicates were
prepared and the Ca, P and Mg content were measured three times each replicate at
analytical emission wavelengths of 422 nm (Ca), 279 nm (Mg) and 214 nm (P).
4.4. In Vitro Studies in Dynamic Conditions
4.4.1. Cell Isolation and Expansion
hMSC were isolated from human bone marrow of femoral heads after informed
consent of the patient and ethical approval (186/18), as previously described [61]. Then,
hMSC were expanded in DMEM GlutaMAX medium (Gibco, Dreieich, Germany) sup-
plemented with 10% FCS (Bio&Sell, Feucht, Germany), 1% Pen/Strep (Sigma-Aldrich),
1% HEPES (Sigma-Aldrich) and 5 ng/mL of recombinant human fibroblast growth factor
(FGF, PeproTech, Hamburg, Germany) at 37 ◦C in a humidified atmosphere of 5% CO2.
Culture medium was replaced 3 times a week. Cells were detached from culture flasks by
trypsinization, centrifuged and resuspended. Cell number and viability were assessed with
the trypan-blue dye exclusion test. hMSC in passage 4–6 were used for the experiments.
hMSC characterization of these cell population, such as surface markers analysis and
in vitro osteogenic and adipogenic potential, have been proven in ref. [62].
4.4.2. Perfusion Bioreactor
This perfusion bioreactor consists of a computer-controlled pump connected by silicon
tubes to a scaffold chamber and a flask reservoir in a closed cyclic system (Figure 7). The
scaffold chamber is sealed with silicone tube with an inner diameter of 10 mm, the same
diameter as the RCP.MgAp scaffolds (Figure 7h). The scaffold chamber was mounted on a
bioreactor cartridge that ensures the homogeneous conditions, avoiding the extravasation of
overflow out of the system, while allowing gas exchange with the bioreactor environment. The
bioreactor was maintained in aseptic conditions in a controlled chamber (Figure 7f) at 37 ◦C
and with 5% CO2. This bioreactor has been satisfactorily used for dynamic culture of hMSC
on synthetic polymeric scaffolds (non-mineralized) to evaluate its osteogenic differentiation
with or without external mechanical stimulation as deformation strain [50,63].
4.4.3. Optimization of hMSC Seeding in 3D Scaffolds
Non-mineralized RCP scaffolds were used as a control for in vitro test. All scaffolds
(10 mm in diameter and 10 mm of height) were pre-incubated with complete culture
medium at 37◦C overnight before cell seeding.
Two different strategies (static and dynamic) of cell seeding were evaluated. For static
seeding, scaffolds were placed in a 24-well plate and each seeded by carefully dropping
100 µL of cell suspension containing 2.0 × 106 cells onto the upper surface, allowing
cell attachment for 90 min at 37 ◦C with 5% CO2. Then, 1.5 mL of expansion medium
supplemented with 10 mM β-glycerophosphate (Sigma-Aldrich), 50 µg/mL L-ascorbic
acid (Sigma-Aldrich) and 100 nM dexamethasone (Sigma-Aldrich) were added to each well
and hMSC were cultured for 1 day.
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Figure 7. Schematic representation of the bioreactor design. The cell culture media is kept in a controlled environment at
37 ◦C in a flask reservoir (a) and driven through silicon tubes with a controllable pump (b) towards the scaffold chamber
(c,h) and back to the reservoir. The system includes additional connections (d) strategically in the inlet and outlet of the
chamber for cell seeding. A valve equipped with a sterile filter (e) on the reservoir guarantees the gas exchange with the
external environment. The pump is programmed to actively perfuse cell culture medium for 5 min at a rate of 1.7 mL/min
and stop for 10 min in cycles of 15 min, as illustrated on the right graph. The incubation chamber (f) includes temperature
and CO2 control where multi bioreactor systems can be mounted in parallel (g).
For dynamic seeding, the scaffolds were placed in the bioreactor chamber and then,
750 µL of cell suspension containing 2.0 × 106 or 5.0 × 106 cells were manually inserted in
the bioreactor chamber through connection named as d (Figure 7). After five backward-
forward cycles, cells were allowed to adhere for 90 min at 37 ◦C with 5% CO2. Then, the
complete supplemented culture medium (35 mL) was added to the reservoir flask and
driven through silicon tubes (towards the scaffold chamber and back to the reservoir) at a
rate of 1.7 mL/min for 5 min every 15 min for 1 day.
Cell viability and distribution in the scaffolds were assessed with MTT [3-(4,5-dimethy
lthiazol-2-yl)-2,5diphenyltetrazolium bromide] assay. Briefly, cell-laden scaffolds were
incubated for 2 h in a solution of 10% MTT (5 mg/mL) in cell culture medium. The
metabolically ac ve cells react with the tetrazolium salt in the MTT re g nt pr ducing
a formazan dye. Pictures of scaffold cross-section were taken under a stereomicroscope
(Zeiss, Discovery.V20).
4.4.4. Osteogenic Differentiation of hMSC under Fl w Perfusion
5.0 × 106 cells were seeded and cultured under dynamic conditions (as previously
described in Section 4.4.2) for 15 days to evaluate the osteogenic differentiation. Media
change was carried out 3 times per week. A total of 3 donors were used as biological replicas
for RCP control samples, while 5 hMSC donors were tested for RCP.MgAp scaffolds.
Cell viability was evaluated by MTT assay (see above). After taking some pictures,
scaffolds were transferred to a tube containing dimethyl sulfoxide (DMSO) that d ssolves
formazan crystal and absorbance was read at 570 nm using a Tecan’s NanoQuant plate
reader.
Int. J. Mol. Sci. 2021, 22, 1447 12 of 15
The osteoblastic differentiation was evaluated by analyzing the expression of os-
teogenic genes by real-time polymerase chain reaction (RT-qPCR). Scaffolds were homog-
enized in 1 mL of TRI Reagent (Sigma-Aldrich) for 5 min at 50 Hz using a QIAGEN
TissueLyser LT (Hilden, Germany). Supernatant was collected and RNA extracted accord-
ing to the manufacturer’s protocol (NucleoSpin RNA, Macherey-Nagel, Dueren, Germany).
cDNA was synthesized using Promega reverse transcriptase reagents. Real-time Poly-
merase chain reaction (PCR) was performed on the CFX96 Real-Time System (Bio-Rad,
Postfach, Germany). Selected osteogenic marker genes were detected using Runx2 (NM
001015051.3), ALP (NM 001631.3), Col1a1 (NM 000088.3), OSX (NM 001173467.2), and
BSP (NM 004967.3) primers, all purchased from Applied Biosystems (Dreieich, Germany).
GAPDH (NM 002046.3) was used as a housekeeping gene. Non-mineralized scaffolds
(RCP) were used as control. Relative quantification of mRNA targets was performed
according to the comparative 2−∆Ct × 1000 method [64].
4.5. Statistical Analysis
Results are expressed as the mean ± standard error of the mean (SEM). Data analy-
sis was made by t-test, followed by non-parametric analysis using Mann–Whitney test.
Statistical analyses were performed with the GraphPad Prism software (version 6.0) and
statistical significance set at p < 0.05
5. Conclusions
In this study, the combination of mineralized recombinant collagen scaffolds in the
presence of magnesium with dynamic culture of hMSC was investigated for the first time.
3D porous structure with suitable pore size and porosity of cell ingrowth was obtained
via freeze-drying. Biomimetic mineralization in the presence of Mg provided a homo-
geneous mineral incorporation into the organic matrix. This mineral phase consisted of
poor crystalline apatite nanoparticles containing carbonate and magnesium, two relevant
ions found in bone apatite. Dynamic seeding of hMSC provided a more uniform cell
distribution along the inner areas of the scaffolds compared to static cell seeding approach,
thus resulting in a genuine 3D culture system. After 15 days of dynamic culture, miner-
alized scaffolds enhanced hMSC viability and showed a clear trend of enhancement of
osteogenic differentiation compared to non-mineralized scaffolds, revealing the pivotal
role of biomimetic mineral phase on cell behavior. Further studies are required in order
to verify this hypothesis and optimize the system towards specialized tissue-engineered
constructs for bone replacement.
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